[go: up one dir, main page]

RU2009119107A - METHOD FOR PREVENTION OF POSTOPERATIVE ADHESIVE PROCESS IN ABDOMINAL CAVITY - Google Patents

METHOD FOR PREVENTION OF POSTOPERATIVE ADHESIVE PROCESS IN ABDOMINAL CAVITY Download PDF

Info

Publication number
RU2009119107A
RU2009119107A RU2009119107/15A RU2009119107A RU2009119107A RU 2009119107 A RU2009119107 A RU 2009119107A RU 2009119107/15 A RU2009119107/15 A RU 2009119107/15A RU 2009119107 A RU2009119107 A RU 2009119107A RU 2009119107 A RU2009119107 A RU 2009119107A
Authority
RU
Russia
Prior art keywords
perftoran
prevention
abdominal cavity
adhesive process
postoperative
Prior art date
Application number
RU2009119107/15A
Other languages
Russian (ru)
Other versions
RU2432944C2 (en
Inventor
Абдурахман Османович Османов (RU)
Абдурахман Османович Османов
Разин Мирзекеримович Рагимов (RU)
Разин Мирзекеримович Рагимов
Original Assignee
Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академи
Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академи, Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" filed Critical Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академи
Priority to RU2009119107/15A priority Critical patent/RU2432944C2/en
Publication of RU2009119107A publication Critical patent/RU2009119107A/en
Application granted granted Critical
Publication of RU2432944C2 publication Critical patent/RU2432944C2/en

Links

Landscapes

  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ профилактики послеоперационного спаечного процесса в брюшной полости, заключающийся в использовании перфторана, отличающийся тем, что перфторан предварительно барботируют озонокислородной смесью с заданной концентрацией озона 5000 мкг/л и к концу операции им орошают органы брюшной полости, исходя из расчета 1 мл/кг массы больного, затем вводят еще столько же озонированного перфторана внутривенно. A method for the prevention of postoperative adhesive process in the abdominal cavity, which consists in the use of perftoran, characterized in that the perftoran is pre-sparged with an ozone-oxygen mixture with a given ozone concentration of 5000 μg / l and by the end of the operation they are irrigated with abdominal organs, based on the calculation of 1 ml / kg of patient weight , then the same amount of ozonized perftoran is administered intravenously.

Claims (1)

Способ профилактики послеоперационного спаечного процесса в брюшной полости, заключающийся в использовании перфторана, отличающийся тем, что перфторан предварительно барботируют озонокислородной смесью с заданной концентрацией озона 5000 мкг/л и к концу операции им орошают органы брюшной полости, исходя из расчета 1 мл/кг массы больного, затем вводят еще столько же озонированного перфторана внутривенно. A method for the prevention of postoperative adhesive process in the abdominal cavity, which consists in the use of perftoran, characterized in that the perftoran is pre-sparged with an ozone-oxygen mixture with a given ozone concentration of 5000 μg / l and by the end of the operation they are irrigated with abdominal organs, based on the calculation of 1 ml / kg of patient weight , then the same amount of ozonized perftoran is administered intravenously.
RU2009119107/15A 2009-05-20 2009-05-20 Method of preventing postoperative commissural process in abdominal cavity RU2432944C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2009119107/15A RU2432944C2 (en) 2009-05-20 2009-05-20 Method of preventing postoperative commissural process in abdominal cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2009119107/15A RU2432944C2 (en) 2009-05-20 2009-05-20 Method of preventing postoperative commissural process in abdominal cavity

Publications (2)

Publication Number Publication Date
RU2009119107A true RU2009119107A (en) 2010-11-27
RU2432944C2 RU2432944C2 (en) 2011-11-10

Family

ID=44057270

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009119107/15A RU2432944C2 (en) 2009-05-20 2009-05-20 Method of preventing postoperative commissural process in abdominal cavity

Country Status (1)

Country Link
RU (1) RU2432944C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2161959C2 (en) * 1996-11-01 2001-01-20 Далгатов Гимат Далгатович Method for preventing connective tissue adhesion
RU2249451C2 (en) * 2003-01-05 2005-04-10 Дагестанская государственная медицинская академия Method for treating acute purulent inflammation in serous cavity

Also Published As

Publication number Publication date
RU2432944C2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
DOP2020000062A (en) PROCEDURE FOR THE PREPARATION OF {4,6-DIAMINE-2- [1- (2-FLUOROBENZYL) -1H-PIRAZOLO [3,4-B] PYRIDIN-3-IL] PYRIMIDIN-5-IL} METHYL METHYLCARBAMATE AND ITS PURIFICATION FOR USE AS A PHARMACEUTICAL ACTIVE SUBSTANCE
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
EP4467160A3 (en) Stabilized liquid and lyophilized adamts13 formulations
EA201270018A1 (en) Opsync ligands, compositions and methods of use
PH12018500639A1 (en) Optimized monoclonal antibodies agaist tissue factor pathway inhibitor (tfpi)
ECSP088902A (en) DERIVATIVES OF PIRAZOLO [3,4-D] -PIRIMIDINE USEFUL TO TREAT RESPIRATORY DISORDERS
MX2010005631A (en) Novel cyclic hydrocarbon compounds for the treatment of diseases.
MX344238B (en) Tetrazole compounds and methods of making and using same.
TN2012000259A1 (en) Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
CY1115961T1 (en) ORVEPITANT MALEATE ANHYDRATED FORM OF CRYSTAL MALINE
WO2008061755A8 (en) Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
BR112013018688A2 (en) process for the production of proanthocyanidin polymer composition
ZA200809686B (en) Lysobactin amindes
RU2009116984A (en) METHOD FOR PREVENTION OF POSTOPERATIVE INTESTINAL PARESIS
RU2009119107A (en) METHOD FOR PREVENTION OF POSTOPERATIVE ADHESIVE PROCESS IN ABDOMINAL CAVITY
EA201070193A1 (en) TREATMENT OF CHILDREN'S TUMORS
AR074724A1 (en) CITRATE SALT 11- (2-PIRROLIDIN-1-IL-ETOXI) -14,19-DIOXA-5,7,26-TRIAZA-TETRACICLO (19.3.1.1 (2,6) .1 (8,12) HEPTACOSE- 1- (25), 2 (26), 3,5,8,10,12 (27), 16,21,23-DECAENE
MD774Y (en) Endoscopic method for treating cirrhotic spontaneous ascites-peritonitis
ES2646628R1 (en) PHARMACEUTICALLY ACTIVATED SUGAR MOLECULE AND ITS SYNTHESIS METHOD
RU2007148938A (en) METHOD FOR PREVENTION OF EARLY POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS
RU2004116284A (en) METHOD FOR BONE CAVITY TREATMENT AFTER NECRSECVESTRECTOMY
RU2010126053A (en) APPLICATION OF SOMATOSTATIN ANALOGUES IN MENINGIOM
RU2007119177A (en) METHOD FOR INCREASING ANTITUMOR CHEMOTHERAPY EFFECT
UA83421U (en) Method for prevention intraabdominal unions after pyoinflammatory diseases of abdominal cavity organs in children

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120521